Barbara E Bierer

Barbara Emily Bierer, MD

Professor of Medicine (Pediatrics), HMS
Member, HMS Center for Bioethics

Barbara Bierer, MD is a Professor of Medicine (Pediatrics) at Harvard Medical School (HMS), and a hematologist/oncologist at the Brigham and Women's Hospital (BWH). She received her MD from HMS. She is the director of the Regulatory Foundations, Law and Ethics Program of the Harvard Catalyst, the Harvard Clinical and Translational Science Award, and the director of regulatory policy, SMART IRB. Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center), a University-wide and collaborative effort to improve the ethics, conduct, and regulatory environment for multi-site, multi-national clinical trials. She is a co-founder of COVID-19 Collaboration Platform, a platform for cooperation in research. In 2017, the MRCT Center launched the non-profit Vivli, a global clinical research data sharing platform. From 2003-2014, she served as Senior Vice President, Research, at BWH and was the institutional official for human subjects and animal research, for biosafety and for research integrity at the BWH. She initiated the Brigham Research Institute and the Innovation Hub (iHub), a focus for entrepreneurship and innovation. Dr. Bierer established and directed the Center for Faculty Development and Diversity at the BWH; for these efforts, she was the first recipient of the HMS Harold Amos Faculty Diversity Award.

Publications View
Separable portions of the CD2 cytoplasmic domain involved in signaling and ligand avidity regulation.
Authors: Authors: Hahn WC, Bierer BE.
J Exp Med
View full abstract on Pubmed
Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology.
Authors: Authors: Bierer BE, Holländer G, Fruman D, Burakoff SJ.
Curr Opin Immunol
View full abstract on Pubmed
Localization of the FK506-binding protein, FKBP 13, to the lumen of the endoplasmic reticulum.
Authors: Authors: Nigam SK, Jin YJ, Jin MJ, Bush KT, Bierer BE, Burakoff SJ.
Biochem J
View full abstract on Pubmed
T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2.
Authors: Authors: Bierer BE, Hahn WC.
Semin Immunol
View full abstract on Pubmed
Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.
Authors: Authors: Wheeler C, Strawderman M, Ayash L, Churchill WH, Bierer BE, Elias A, Gilliland DG, Antman K, Guinan EC, Eder JP, et al.
J Clin Oncol
View full abstract on Pubmed
The complete sequences of plasmids pFNeo and pMH-Neo: convenient expression vectors for high-level expression of eukaryotic genes in hematopoietic cell lines.
Authors: Authors: Hahn WC, Menzin E, Saito T, Germain RN, Bierer BE.
Gene
View full abstract on Pubmed
Signal transduction pathways involved in T cell receptor-induced regulation of CD2 avidity for CD58.
Authors: Authors: Hahn WC, Burakoff SJ, Bierer BE.
J Immunol
View full abstract on Pubmed
A role for calcineurin in degranulation of murine cytotoxic T lymphocytes.
Authors: Authors: Dutz JP, Fruman DA, Burakoff SJ, Bierer BE.
J Immunol
View full abstract on Pubmed
Association of CD2 with tubulin. Evidence for a role of the cytoskeleton in T cell activation.
Authors: Authors: Offringa R, Bierer BE.
J Biol Chem
View full abstract on Pubmed
Cell-mediated immunity.
Authors: Authors: Goust JM, Bierer B.
Immunol Ser
View full abstract on Pubmed